Evidence map›Paper›PMID 23723068›Full record

ArticleThe Journal of biological chemistry2013

Regulation of phospholipase D activity and phosphatidic acid production after purinergic (P2Y6) receptor stimulation.

Sarah A Scott, Yun Xiang, Thomas P Mathews, Hyekyung P Cho, David S Myers, Michelle D Armstrong, Keri A Tallman, Matthew C O'Reilly, Craig W Lindsley, H Alex Brown

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Frontiers in physiology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sarah A ScottDepartment of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.
Yun Xiang
Thomas P Mathews
Hyekyung P Cho
David S Myers
Michelle D Armstrong
Keri A Tallman
Matthew C O'Reilly
Craig W Lindsley
H Alex Brown
Vanderbilt University Medical Center · USVanderbilt University · US

Funding

The Vanderbilt Specialized Chemistry Center for Accelerated Probe DevelopmentU54MH084659 · NIMH · VANDERBILT UNIVERSITY · PI MEILER, JENS · 2008 to 2013
$24.1M
Protein Adducts and Proteome Profiles in Oxidative StressP01ES013125 · NIEHS · VANDERBILT UNIVERSITY · PI PORTER, NED ALLEN · 2005 to 2012
$12.6M
MULTIDISCIPLINARY BASIC RESEARCH TRAINING IN CANCERT32CA009592 · NCI · VANDERBILT UNIVERSITY · PI Justin M Balko, Julie A Rhoades (Sterling) · 1987 to 2026
$10.4M
Postdoctoral Training in CNS Drug Discovery ResearchT32MH093366 · NIMH · VANDERBILT UNIVERSITY · PI CONN, P JEFFREY · 2011 to 2015
$1.0M
NCI NIH HHS T32 CA009592NIEHS NIH HHS P01 ES013125NIEHS NIH HHS P01-ES013125NIMH NIH HHS T32 MH093366NIMH NIH HHS U54 MH084659PHS HHS U54 069338
6 · The paper itself

Abstract

Phosphatidic acid (PA) is a lipid second messenger located at the intersection of several lipid metabolism and cell signaling events including membrane trafficking, survival, and proliferation. Generation of signaling PA has long been primarily attributed to the activation of phospholipase D (PLD). PLD catalyzes the hydrolysis of phosphatidylcholine into PA. A variety of both receptor-tyrosine kinase and G-protein-coupled receptor stimulations have been shown to lead to PLD activation and PA generation. This study focuses on profiling the PA pool upon P2Y6 receptor signaling manipulation to determine the major PA producing enzymes. Here we show that PLD, although highly active, is not responsible for the majority of stable PA being produced upon UDP stimulation of the P2Y6 receptor and that PA levels are tightly regulated. By following PA flux in the cell we show that PLD is involved in an initial increase in PA upon receptor stimulation; however, when PLD is blocked, the cell compensates by increasing PA production from other sources. We further delineate the P2Y6 signaling pathway showing that phospholipase Cβ3 (PLCβ3), PLCδ1, DGKζ and PLD are all downstream of receptor activation. We also show that DGKζ is a novel negative regulator of PLD activity in this system that occurs through an inhibitory mechanism with PKCα. These results further define the downstream events resulting in PA production in the P2Y6 receptor signaling pathway.

Indexed as

1-ButanolBlotting, WesternCell Line, TumorDiacylglycerol KinaseDiglyceridesDose-Response Relationship, DrugEnzyme InhibitorsHumansHydrolysisIsoenzymesMass SpectrometryModels, BiologicalPhosphatidic AcidsPhosphatidylcholinesPhospholipase C deltaPhospholipase D1-ButanolDGKZ protein, humanDiacylglycerol KinaseDiglyceridesEnzyme InhibitorsIsoenzymesPhosphatidic AcidsPhosphatidylcholinesPhospholipase C deltaPhospholipase DPLCD1 protein, humanProtein Kinase C-alphapurinoceptor P2Y6Receptors, Purinergic P2Uridine DiphosphateDAG KinaseDiacylglycerolLipidomicsPhosphatidic AcidPhospholipase DProtein Kinase C (PKC)Purinergic Receptor

Identifiers

PMID23723068
PMCPMC3711313
OpenAlexW2043499332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.